Citigroup Inc. Decreases Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Citigroup Inc. cut its stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 17.7% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 115,261 shares of the company's stock after selling 24,729 shares during the quarter. Citigroup Inc. owned 0.09% of Henry Schein worth $8,403,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in HSIC. Cromwell Holdings LLC grew its stake in shares of Henry Schein by 93.4% in the third quarter. Cromwell Holdings LLC now owns 352 shares of the company's stock worth $26,000 after acquiring an additional 170 shares during the period. Summit Securities Group LLC bought a new stake in shares of Henry Schein in the second quarter worth approximately $31,000. Beach Investment Counsel Inc. PA bought a new stake in shares of Henry Schein in the second quarter worth approximately $37,000. Blue Trust Inc. grew its position in Henry Schein by 104.2% during the second quarter. Blue Trust Inc. now owns 931 shares of the company's stock valued at $60,000 after buying an additional 475 shares during the period. Finally, Farther Finance Advisors LLC grew its position in Henry Schein by 58.9% during the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company's stock valued at $68,000 after buying an additional 346 shares during the period. 96.62% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

HSIC has been the subject of several recent research reports. Robert W. Baird cut their target price on shares of Henry Schein from $92.00 to $82.00 and set an "outperform" rating for the company in a research report on Wednesday, August 7th. Barrington Research restated an "outperform" rating and set a $82.00 target price on shares of Henry Schein in a research report on Wednesday, November 6th. JPMorgan Chase & Co. cut their target price on shares of Henry Schein from $88.00 to $80.00 and set an "overweight" rating for the company in a research report on Monday, August 12th. Evercore ISI boosted their target price on shares of Henry Schein from $70.00 to $74.00 and gave the company an "in-line" rating in a research report on Tuesday, October 8th. Finally, UBS Group cut their target price on shares of Henry Schein from $75.00 to $72.00 and set a "neutral" rating for the company in a research report on Wednesday, August 7th. Six equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $79.38.

Henry Schein Price Performance

Shares of NASDAQ:HSIC opened at $77.05 on Friday. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. Henry Schein, Inc. has a 1-year low of $63.67 and a 1-year high of $82.63. The company has a market capitalization of $9.61 billion, a P/E ratio of 31.71, a P/E/G ratio of 2.23 and a beta of 0.87. The firm's 50 day simple moving average is $71.36 and its two-hundred day simple moving average is $69.89.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, topping the consensus estimate of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. During the same quarter in the previous year, the firm earned $1.32 earnings per share. The company's quarterly revenue was up .4% compared to the same quarter last year. Research analysts expect that Henry Schein, Inc. will post 4.78 EPS for the current fiscal year.

Insider Transactions at Henry Schein

In other news, COO Michael S. Ettinger sold 12,240 shares of the business's stock in a transaction on Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the transaction, the chief operating officer now owns 87,706 shares of the company's stock, valued at approximately $6,577,950. The trade was a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Lorelei Mcglynn sold 21,035 shares of the business's stock in a transaction on Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the transaction, the senior vice president now directly owns 71,833 shares in the company, valued at $4,978,026.90. This trade represents a 22.65 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.14% of the company's stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.